All the Active Ingredient Drugs
Trelegy Ellipta 92/55/22 mcg
GSK
Trelegy Ellipta 92/55/22 mcg
Corticosteroid, LABA, Long-acting Muscarinic Receptor Antagonist. Fluticasone Furoate 92 mcg, Umeclidinium Bromide 65 mcg, Vilanterol (as trifenatate) 22 mcg. INHALAT. PWDR., PRE-DISPENS.: 1×14, 30 doses. Applied once dly. See lit.
Long-term, once-dly., maintenan. tmt. of airflow obstruct. in pts. with COPD, includ. chron. bronchit. and/or emphysema.
Indicated to reduce exacerbat. of COPD in pts. with a history of exacerbat.
Important Limitations of Use: NOT indicat. for the relief of acute bronchospasm or for the tmt. of asthma.
C/I: Hypersens.